Abstract
Hepatoblastoma is a highly malignant embryonal liver tumor that occurs almost exclusively in infants and toddlers. Trisomy 18 is the second most common autosomal trisomy after trisomy 21 and is generally considered a lethal disorder. Ten cases of hepatoblastoma in children with trisomy 18 have been published to date. Here, we report on two female patients with trisomy 18 and pretreatment extent of disease (PRETEXT) stage 1 hepatoblastoma, which support the presence of a nonrandom association between hepatoblastoma and trisomy 18. Both patients underwent primary surgical resection without any neoadjuvant or adjuvant chemotherapy. The histologies returned as pure fetal epithelial type, and combined fetal and embryonal epithelial type. There was no evidence of recurrence on serial abdominal ultrasound and serum alpha-fetoprotein levels on follow-up. Conclusion: Primary surgical resection is a treatment approach that can be considered in children with trisomy 18 and PRETEXT stage 1 tumor. However, in view of the overall prognosis for trisomy 18, the decision on the optimal treatment is a delicate one and has to be individualized in the context of the best interests of the child.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha-fetoprotein
- ASD:
-
Atrial septal defect
- BWS:
-
Beckwith–Wiedemann syndrome
- COG:
-
Children’s oncology group
- CT:
-
Computed tomography
- IHH:
-
Isolated hemihyperplasia
- PDA:
-
Patent ductus arteriosus
- PRETEXT:
-
Pretreatment extent of disease
- VSD:
-
Ventricular septal defect
References
Janvier A, Farlow B, Wilfond BS (2012) The experience of families with children with trisomy 13 and 18 in social networks. Pediatrics 130:293–8
Kelly M, Robinson BW, Moore JW (2002) Trisomy 18 in a 20-year-old woman. Am J Med Genet 112:397–9
Kosho T, Nakamura T, Kawame H, Baba A, Tamura M, Fukushima Y (2006) Neonatal management of trisomy 18: clinical details of 24 patients receiving intensive treatment. Am J Med Genet A 140:937–44
Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK (1985) Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316:330–4
Maeda J, Yamagishi H, Furutani Y, Kamisago M, Waragai T, Oana S, Kajino H, Matsuura H, Mori K, Matsuoka R, Nakanishi T (2011) The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet A 155:2641–6
McGraw MP, Perlman JM (2008) Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic. Pediatrics 121:1106–1110
Pereira EM, Marion R, Ramesh KH, Kim JS, Ewart M, Ricafort R (2012) Hepatoblastoma in a mosaic trisomy 18 patient. J Pediatr Hematol Oncol 34:e145–e148
Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM (2003) Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111:777–84
Uekusa S, Sugito K, Kawashima H, Yoshizawa S, Furuya T, Ohashi K, Ikeda T, Koshinaga T, Mugishima H (2012) Successful treatment for hepatoblastoma in a 1-year-old boy with trisomy 18. Pediatr Int 54:428–30
von Schweinitz D (2012) Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 21:21–30
Conflict of interest
The authors declare that they have no financial relationships or conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, Z.H., Lai, A., Chen, C.K. et al. Association of trisomy 18 with hepatoblastoma and its implications. Eur J Pediatr 173, 1595–1598 (2014). https://doi.org/10.1007/s00431-013-2147-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-013-2147-8